Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	1.98	2.55	0.26
Other Operating Activities	-3.31	-3.62	-0.3
Change in Other Net Operating Assets	0.6	0.39	0.04
Operating Cash Flow	-0.73	-0.67	-
Other Investing Activities	30.51	-0.28	-104.54
Investing Cash Flow	30.51	-0.28	-104.54
Short-Term Debt Issued	-	0.4	-
Total Debt Issued	1.08	0.4	0.31
Total Debt Repaid	-	-	-0.32
Net Debt Issued (Repaid)	1.08	0.4	-0.01
Issuance of Common Stock	-	-	108.52
Other Financing Activities	-	-	-3.11
Financing Cash Flow	-30.19	0.4	105.41
Net Cash Flow	-0.41	-0.55	0.87
Levered Free Cash Flow	-	-0.1	-
Unlevered Free Cash Flow	-	-0.1	-
Change in Net Working Capital	-	-0.56	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q